NITE Insider Trading Activity and SEC Form 4 Filings
NITE insider trading summary
No open-market insider purchases or sales of Nightstar Therapeutics plc (NITE) have been reported on SEC Form 4 in the past 12 months.
Latest NITE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 1, 2019 | Tuyen Ong | Chief Development Officer | Sell | $62K (2,446 @ $25.31) |
| Apr 1, 2019 | Gregory Scott Robinson | Chief Scientific Officer | Sell | $10K (410 @ $25.31) |
| Apr 1, 2019 | David A Fellows | Chief Executive Officer | Sell | $236K (9,305 @ $25.31) |
| Apr 1, 2019 | Senthil Vel Sundaram | Chief Financial Officer | Sell | $10K (391 @ $25.31) |
| Jan 7, 2019 | David A Fellows | Chief Executive Officer | Sell | $113K (8,733 @ $12.98) |
| Jan 7, 2019 | Gregory Scott Robinson | Chief Scientific Officer | Sell | $8K (425 @ $19.98) |
| Jan 7, 2019 | Senthil Vel Sundaram | Chief Financial Officer | Sell | $5K (406 @ $12.98) |
| Jan 7, 2019 | Tuyen Ong | Chief Development Officer | Sell | $33K (2,546 @ $12.98) |
| Jan 3, 2019 | Tuyen Ong | Chief Development Officer | Sell | $49K (4,070 @ $12.00) |
| Jan 2, 2019 | Gregory Scott Robinson | Chief Scientific Officer | Sell | $165K (14,764 @ $11.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.